Lexicon Pharmaceuticals's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Lexicon Pharmaceuticals (NASDAQ:LXRX) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.21. The company's past performance shows a pattern of share price changes following earnings reports. The company's shares were trading at $1.29 as of November 6, and over the last 52-week period, shares are down 35.71%.
November 07, 2023 | 4:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Lexicon Pharmaceuticals is expected to report an EPS of $-0.21 in its upcoming earnings report. The company's share price has historically been affected by its earnings reports.
Lexicon Pharmaceuticals' share price has historically been affected by its earnings reports. Given that the company's shares are down 35.71% over the last 52 weeks, and the estimated EPS is negative, it is likely that the upcoming earnings report could negatively impact the share price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100